Clinical Trials List
2018-04-19 - 2023-12-31
Phase III
Terminated6
ICD-10C16
Malignant neoplasm of stomach
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳炯年 Division of General Surgery
- Chih-Hung Hsu Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- MING-TSAN LIN Division of General Surgery
- 李柏居 Division of General Surgery
- 林宗哲 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 楊博仁 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- I-RUE LAI Division of General Surgery
- Chiun Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- 徐潤德 Division of General Surgery
- 洪建福 Division of Radiology
- Jen-Shi Chen Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Tai-Sen Yeh Division of General Surgery
- Wen-Chi Chou Division of Hematology & Oncology
- 劉耿豪 Division of General Surgery
- 曾振輝 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 趙盈瑞 Division of General Surgery
- Chien-Jui Huang Digestive System Department
- Yan-Shen Shan Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- Huey-En Tzeng Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- YEN-HAO SU Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20~38 participants
-
Global
1000 participants
